Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W. Wang

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

Journal of Thoracic Oncology

English

P1.03-33 Mutational Spectrum and Prognosis of Non-Small-Cell Lung Cancer Harboring MTOR Mutations in Chinese Population

Journal of Thoracic Oncology

English

P2.01-117 Concurrent Gene Alterations in Treatment-Naïve EGFR-Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Journal of Thoracic Oncology

English

P3.cr-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report

Journal of Thoracic Oncology

English

P1.03-03 Molecular Characteristics of Chinese Patients With TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

Journal of Thoracic Oncology

English

P1.03-32 Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P2.03-35 Non-Small-Cell Lung Cancer With SMO Gene Variants of Uncertain Significance Share Distinct Molecular Features

Journal of Thoracic Oncology

English

P3.cr-04 Lung Cancer With Concurrent ROS1 Rearrangement and KRAS Mutation: A Case Report

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W. Wang

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

P1.03-33 Mutational Spectrum and Prognosis of Non-Small-Cell Lung Cancer Harboring MTOR Mutations in Chinese Population

P2.01-117 Concurrent Gene Alterations in Treatment-Naïve EGFR-Mutant Advanced Non-Small Cell Lung Cancer

P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

P3.cr-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report

P1.03-03 Molecular Characteristics of Chinese Patients With TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

P1.03-32 Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients

P2.03-35 Non-Small-Cell Lung Cancer With SMO Gene Variants of Uncertain Significance Share Distinct Molecular Features

P3.cr-04 Lung Cancer With Concurrent ROS1 Rearrangement and KRAS Mutation: A Case Report